Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q2 2023 Earnings Call Transcript

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q2 2023 Earnings Call Transcript August 15, 2023

Operator: Good morning. Welcome to the Inhibikase Therapeutics Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Alex Lobo, Stern Investor Relations. Please go ahead.

Alex Lobo: Good morning and welcome to the Inhibikase Therapeutics second quarter 2023 financial results conference...